Best treatments for renal cell carcinoma
29 products may treat renal cell carcinoma, spanning FDA drug classes such as programmed death receptor-1 blocking antibody, progestin, interferon gamma. The current highest-rated option is keytruda. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 29 drugs we list for renal cell carcinoma, 7 are available as lower-cost generics, spanning classes such as programmed death receptor-1 blocking antibody, progestin, interferon gamma. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for renal cell carcinoma — so confirm the right choice with your prescriber.
Understanding renal cell carcinoma
Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. According to the National Cancer Institute (NCI), it begins in the lining of the tiny tubes (tubules) inside the kidney that filter blood and make urine. In its early stages it often causes no signs or symptoms. When symptoms do appear, NCI lists possibilities such as blood in the urine, a lump in the abdomen, pain in the side that does not go away, loss of appetite, unexplained weight loss, or anemia. Because these symptoms can have many causes, they do not by themselves mean cancer is present. To evaluate a possible kidney tumor, doctors may use blood and urine tests and imaging such as ultrasound, CT, or MRI, and in some cases a biopsy, in which a tissue sample is examined under a microscope. If cancer is confirmed, it is staged (commonly using the TNM system) to describe the tumor's size and whether it has spread, which helps guide how it is managed. This is general information, not medical advice.
First-line treatment
Per NCI and the American Cancer Society, there is no single "first-line" treatment that fits everyone. The type of treatment recommended depends mainly on the stage of the cancer and the person's overall health, and also on tumor characteristics (such as whether it is clear cell or non-clear cell RCC) and personal preferences. Diagnosis and staging inform which options are considered. Broad categories include active surveillance for some small tumors; surgery (such as partial or radical nephrectomy); ablation (for example cryotherapy or radiofrequency ablation); radiation therapy; targeted therapy (drugs aimed at specific features of cancer cells); and immunotherapy (which helps the immune system fight cancer). Treatment is often individualized and may combine approaches. Decisions are made by a multidisciplinary oncology team together with the patient. This is general information, not medical advice.
Top-rated picks for renal cell carcinoma: 1. Keytruda · 2. Resniben · 3. Votrient
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Injectable | Programmed Death Receptor-1 Blocking Antibody | No data | — | View → | |
| 2 | 70/100 | Prescription | Tablet | — | No data | — | View → | |
| 3 | 70/100 | Prescription | Tablet | — | No data | — | View → | |
| 4 | 68/100 | Prescription | Kit | — | No data | — | View → | |
| 5 | 64/100 | Prescription | Injectable | Progestin | Generic | $563 | View → | |
| 6 | 64/100 | Prescription | Injectable | Progestin | Generic | $563 | View → | |
| 7 | 64/100 | Prescription | Tablet | Progestin | Generic | $563 | View → | |
| 8 | Not yet rated | Prescription | Injectable | Interferon gamma | No data | — | View → | |
| 9 | Not yet rated | Prescription | Injectable | — | No data | — | View → | |
| 10 | Not yet rated | Prescription | Tablet | Kinase Inhibitor | No data | — | View → |
Narrow by drug class
Explore the class hubs: kinase inhibitor · progestin
Full ranking · 29 treatments
keytruda
PrescriptionFDA-sourced
Keytruda (Pembrolizumab) is a programmed death receptor-1 blocking antibody used to treat Malignant Mesothelioma, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma.
Price varies
resniben
PrescriptionFDA-sourced
Resniben (Cabozantinib) is a medication used to treat Renal Cell Carcinoma.
Price varies
votrient
Boxed warningPrescriptionFDA-sourced
Votrient (Pazopanib Hydrochloride) is a medication used to treat Renal Cell Carcinoma, Soft Tissue Neoplasms.
Price varies
betaseron
PrescriptionFDA-sourced
Betaseron (Interferon Beta-1b) is a medication used to treat Multiple Sclerosis, Brain Neoplasms, Renal Cell Carcinoma, Cryoglobulinemia.
Price varies
depo-provera
Boxed warningPrescriptionFDA-sourced
Depo-Provera (Medroxyprogesterone Acetate) is a progestin used to treat Amenorrhea, Breast Neoplasms, Renal Cell Carcinoma, Endometrial Hyperplasia.
Pharmacy pays
From ~$3.49/30· 4 forms Save up to 99% in classdepo-subq provera 104
Boxed warningPrescriptionFDA-sourced
Depo-Subq Provera 104 (Medroxyprogesterone Acetate) is a progestin used to treat Amenorrhea, Breast Neoplasms, Renal Cell Carcinoma, Endometrial Hyperplasia.
Pharmacy pays
From ~$3.49/30· 4 forms Save up to 99% in class- Provera
- Actimmune
- Alferon N Injection
- Cabometyx
- Cometriq
- Droxia
- Fotivda
- Hydrea
- Inlyta
- Intron A
- Lenvima
- Nexavar
- Pazopanib Hydrochloride
- Pegasys
- Pegintron
- Proleukin
- Siklos
- Sorafenib Tosylate
- Sutent
- Sylatron
- Thalomid
- Torisel
- Xromi
Frequently asked
- What treats renal cell carcinoma?
- Our catalog lists 29 products that may treat renal cell carcinoma, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is keytruda.
- What is the best-rated treatment for renal cell carcinoma?
- By our independent recall-safety rating — not an efficacy measure — keytruda ranks highest among the products we list for renal cell carcinoma. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat renal cell carcinoma?
- Treatments for renal cell carcinoma span FDA drug classes including programmed death receptor-1 blocking antibody, progestin, interferon gamma, kinase inhibitor, lymphocyte growth factor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.